477 results on '"Herfarth, H."'
Search Results
2. P547 Rate of Colectomy Increases within Twelve Months of Sequential Therapy for Ulcerative Colitis
3. DOP35 Increasing incidence of pouchitis among patients undergoing ileal pouch-anal anastomosis between 1996 and 2018: A population-based Danish cohort study
4. Comparison of different scoring systems to classify reflux esophagitis
5. Kolitis induzierende T-Zellen migrieren verstärkt in den Appendix
6. Synthetischer TNF-α Blocker (Allotrap 1258) reduziert Leukozytenadhäsion und -migration bei akuter Kolitis
7. Extravasation von in vivo aktivierten T- Lymphozyten in das Kolon
8. MadCAM-1-Blockade reduziert Leukozytenextravasation in vivo bei experimenteller chronischer Kolitis
9. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
10. Internistische Indikation zur Magnetresonanztomographie: Wann brauchen wir sie wirklich?
11. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
12. MR colonography in inflammatory bowel disease
13. Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor
14. Rolle der Hämoxygenase-1(HO-1) bei der Pathogenese der Kolitis
15. Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization
16. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis
17. Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease
18. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-[kappa]B signal transduction and IL-8 gene expression in colonic epithelial cells
19. Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab
20. Inducible CD40 expression mediates NFκB activation and cytokine secretion in human colonic fibroblasts
21. Comment on: Prospective cohort study of appendicectomy for treatment of therapy-refractory ulcerative colitis
22. Evaluation of a Non-invasive Method to Detect Cytomegalovirus (CMV)-DNA in Stool Samples of Patients with Inflammatory Bowel Disease (IBD): A Pilot Study
23. Significant Differences Between Crohnʼs Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients
24. (GT)n Dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course
25. Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD
26. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis
27. Kolitis induzierende T-Zellen migrieren verstärkt in den Appendix
28. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn’s disease
29. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo
30. Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes
31. Dose dependency of fermentation and the extent of renal excretion of Palatinit (Isomalt) in rats with respect to its energy value
32. Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice
33. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the −2518 A→G promoter polymorphism
34. Creeping fat in Crohn’s disease: travelling in a creeper lane of research?
35. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis
36. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study
37. NOD2/CARD15 Mutations and Outcome Following Allogeneic SCT: Strong Impact in Patients Requiring Treatment of GvHD: O289
38. Morphological characterisation of Crohn’s disease fistulae
39. Cathepsin D is up-regulated in inflammatory bowel disease macrophages
40. NOD2/CARD15 mutations of recipients and donors associate with GvHD and TRM following allogeneic stem cell transplantation - results in 2 independent cohorts of patients
41. The virtuosity of virtuality or how real is virtual colonography
42. Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis
43. IL-10 therapy in Crohn's disease: at the crossroads
44. Quantification of mucosal leucocyte endothelial cell interaction by in vivo fluorescence microscopy in experimental colitis in mice
45. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohnʼs disease intestinal macrophages
46. Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin
47. P591 Low donor microbial engraftment after combined endoscopic and oral faecal microbiota transplant (FMT) in patients with antibiotic dependent pouchitis
48. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers
49. Erratum to: MR colonography in inflammatory bowel disease
50. Sensitivität von nichtärztlichen Untersuchern bei der Beurteilung von Vidoekapselendoskopien (VKE)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.